中国结直肠癌的治疗现状：一项系统综述
The current status of treatment for colorectal cancer in China: A systematic review.
作者信息
Zhang Yumei, Chen Zhiyu, Li Jin
机构信息
Department of VIP Clinic, Tongji University South Branch of Shanghai East Hospital Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College Department of Oncology, Tongji University Shanghai East Hospital, Shanghai, China.
出版信息
Medicine (Baltimore). 2017 Oct;96(40):e8242. doi: 10.1097/MD.0000000000008242.
Abstract
BACKGROUND
Colorectal cancer (CRC) is one of the most common cancers all over the world, but its epidemiology is obviously different in various regions.
METHODS
The treatment of CRC also has varying characteristics due to differences in economy, geography, disease onset, chemotherapy, and other factors, although international guidelines are used to guide the treatment of CRC in China.
RESULTS
This paper summarizes the current status of CRC treatment, including surgical therapy, neoadjuvant radiotherapy and chemotherapy, postoperative chemotherapy, targeted therapy, maintenance therapy, and immunotherapy, according to the clinical situation in China, so as to provide better therapy and improve clinical practice for patients with CRC.
CONCLUSION
This research shows that the treatment of colorectal cancer continues to progress, and the patient's efficacy and quality of life have improved.
摘要
背景
结直肠癌（CRC）是全球最常见的癌症之一，但其流行病学在不同地区存在明显差异。
方法
尽管中国采用国际指南指导结直肠癌的治疗，但由于经济、地理、疾病发病情况、化疗等因素的差异，结直肠癌的治疗也具有不同特点。
结果
本文根据中国的临床情况，总结了结直肠癌治疗的现状，包括手术治疗、新辅助放疗和化疗、术后化疗、靶向治疗、维持治疗和免疫治疗，以便为结直肠癌患者提供更好的治疗并改善临床实践。
结论
本研究表明，结直肠癌的治疗不断进步，患者的疗效和生活质量得到了提高。
相似文献
1
The current status of treatment for colorectal cancer in China: A systematic review.中国结直肠癌的治疗现状：一项系统综述
Medicine (Baltimore). 2017 Oct;96(40):e8242. doi: 10.1097/MD.0000000000008242.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织（EORTC）癌症贫血患者促红细胞生成蛋白使用指南：2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌：系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益：一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理：一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
引用本文的文献
1
The association between neutrophil percentage to albumin ratio and progression-free survival and overall survival in colorectal cancer patients: a retrospective cohort study.中性粒细胞百分比与白蛋白比值与结直肠癌患者无进展生存期和总生存期的关联：一项回顾性队列研究。
Front Nutr. 2025 Jul 10;12:1589854. doi: 10.3389/fnut.2025.1589854. eCollection 2025.
2
Self-Care Experiences of Patients Who Have Recently Undergone Colostomy: A Qualitative Study.近期接受结肠造口术患者的自我护理体验：一项定性研究
Nurs Open. 2025 May;12(5):e70193. doi: 10.1002/nop2.70193.
3
RBM39 Functions as a Potential Oncogene Through the NF-κB Signaling Pathway in Colorectal Cancer Cells.RBM39通过NF-κB信号通路在结肠癌细胞中发挥潜在癌基因的作用。
J Cancer. 2025 Mar 29;16(7):2233-2249. doi: 10.7150/jca.105120. eCollection 2025.
4
Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers-From Inflammation to Cancer.胰腺癌和肝癌中的色素上皮衍生因子——从炎症到癌症
Biomedicines. 2024 Oct 4;12(10):2260. doi: 10.3390/biomedicines12102260.
5
Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer.基因芯片分析表明，LMNB1 和 JUN 可能是依托泊苷促进结直肠癌转移的潜在预测靶点。
Sci Rep. 2024 Oct 10;14(1):23661. doi: 10.1038/s41598-024-72674-8.
6
The Anthraquinone Derivative C2 Enhances Oxaliplatin-Induced Cell Death and Triggers Autophagy via the PI3K/AKT/mTOR Pathway.蒽醌衍生物 C2 通过 PI3K/AKT/mTOR 通路增强奥沙利铂诱导的细胞死亡并触发自噬。
Int J Mol Sci. 2024 Jun 12;25(12):6468. doi: 10.3390/ijms25126468.
7
Oleuropein impact on colorectal cancer.橄榄苦苷对结直肠癌的影响。
Future Sci OA. 2024 May 23;10(1):FSO. doi: 10.2144/fsoa-2023-0131. eCollection 2024.
8
Depletion of CPNE7 sensitizes colorectal cancer to 5-fluorouracil by downregulating ATG9B expression.CPNE7 耗竭通过下调 ATG9B 表达使结直肠癌对 5-氟尿嘧啶敏感。
J Cell Mol Med. 2024 Apr;28(8):e18261. doi: 10.1111/jcmm.18261.
9
Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.结直肠癌患者术前及术后肿瘤标志物动态变化的预后价值
Clin Transl Oncol. 2024 Aug;26(8):2047-2059. doi: 10.1007/s12094-024-03429-0. Epub 2024 Mar 7.
10
DPY30 knockdown suppresses colorectal carcinoma progression via inducing Raf1/MST2-mediated apoptosis.DPY30基因敲低通过诱导Raf1/MST2介导的凋亡抑制结直肠癌进展。
Heliyon. 2024 Jan 20;10(3):e24807. doi: 10.1016/j.heliyon.2024.e24807. eCollection 2024 Feb 15.
本文引用的文献
1
Intratumoral FoxP3Helios Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer.上调免疫抑制分子的肿瘤内FoxP3Helios调节性T细胞在人类结直肠癌中扩增。
Front Immunol. 2017 May 26;8:619. doi: 10.3389/fimmu.2017.00619. eCollection 2017.
2
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy.右侧与左侧转移性结直肠癌：肿瘤生物学及贝伐单抗疗效的差异
Int J Mol Sci. 2017 Jun 9;18(6):1240. doi: 10.3390/ijms18061240.
3
Trends and Outcomes of Surgical Treatment for Colorectal Cancer between 2004 and 2012- an Analysis using National Inpatient Database.2004 年至 2012 年期间，使用国家住院患者数据库分析结直肠癌的手术治疗趋势和结果。
Sci Rep. 2017 May 17;7(1):2006. doi: 10.1038/s41598-017-02224-y.
4
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.在六个随机试验中，接受化疗和 EGFR 靶向抗体治疗的 RAS 野生型转移性结直肠癌患者中，原发肿瘤侧的预后和预测价值。
Ann Oncol. 2017 Aug 1;28(8):1713-1729. doi: 10.1093/annonc/mdx175.
5
Complete mesocolic excision in right hemicolectomy: comparison between hand-assisted laparoscopic and open approaches.右半结肠切除术中的完整结肠系膜切除术：手辅助腹腔镜手术与开放手术的比较
Ann Surg Treat Res. 2017 Feb;92(2):90-96. doi: 10.4174/astr.2017.92.2.90. Epub 2017 Jan 31.
6
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.呋喹替尼在既往接受过治疗的转移性结直肠癌患者中的安全性和有效性：一项Ib期研究和一项随机双盲II期研究。
J Hematol Oncol. 2017 Jan 19;10(1):22. doi: 10.1186/s13045-016-0384-9.
7
Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients.不同位置结直肠癌的特征支持近端和远端分类：一项基于57847例患者的人群研究
PLoS One. 2016 Dec 9;11(12):e0167540. doi: 10.1371/journal.pone.0167540. eCollection 2016.
8
Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases.同期肝切除对同时性结直肠癌肝转移患者有益。
Chin J Cancer Res. 2016 Oct;28(5):528-535. doi: 10.21147/j.issn.1000-9604.2016.05.08.
9
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.维莫非尼联合伊立替康和西妥昔单抗治疗BRAFV600E突变转移性结直肠癌患者的I B期研究
Cancer Discov. 2016 Dec;6(12):1352-1365. doi: 10.1158/2159-8290.CD-16-0050. Epub 2016 Oct 11.
10
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.RAS野生型转移性结直肠癌患者中原发肿瘤部位的预后和预测相关性：CRYSTAL和FIRE-3试验的回顾性分析
JAMA Oncol. 2017 Feb 1;3(2):194-201. doi: 10.1001/jamaoncol.2016.3797.
Zotero 插件